|
Index of reports
> Death (21)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Betamethasone (Betamethasone Topical) death. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Betamethasone side effects in
Reported by a physician from Japan on 2012-08-25
Patient:
Reactions: Pneumocystis Jiroveci Pneumonia, Multi-Organ Failure, Disseminated Intravascular Coagulation, Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Betamethasone
Dosage: 4 mg, qd
Temodal
Indication: Glioblastoma
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-23
Patient:
Reactions: LOW Birth Weight Baby, Premature Baby, Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Progesterone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Progesterone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in
Reported by a physician from Poland on 2012-07-13
Patient:
Reactions: Foetal Exposure During Pregnancy, Death Neonatal
Adverse event resulted in: death
Drug(s) suspected as cause:
Progesterone
Indication: Maternal Exposure Timing Unspecified
Verapamil HCL
Indication: Maternal Exposure Timing Unspecified
Betamethasone
Indication: Maternal Exposure Timing Unspecified
Fenoterol Hydrobromide
Indication: Maternal Exposure Timing Unspecified
Possible Betamethasone side effects in 75 year old female
Reported by a physician from Japan on 2012-06-08
Patient: 75 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Fungal Sepsis, Coma, Myopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Dosage: 4 mg/day
Indication: Asthma
Solu-Cortef
Dosage: 400 mg/day
Other drugs received by patient: Theophylline
Possible Betamethasone side effects in 75 year old female
Reported by a physician from Japan on 2012-05-31
Patient: 75 year old female, weighing 75.0 kg (165.0 pounds)
Reactions: Coma, Fungal Sepsis, Myopathy
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydrocortisone Sodium Succinate
Dosage: 400 mg/day
Indication: Asthma
Betamethasone
Dosage: 4 mg/day
Indication: Asthma
Other drugs received by patient: Theophylline
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2012-05-22
Patient: 74 year old female, weighing 44.5 kg (97.9 pounds)
Reactions: Diabetes Mellitus, Neoplasm Progression, Brain Neoplasm
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Temodal
Dosage: 100 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-05-25
End date: 2011-05-29
Temodal
Dosage: 100 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-02-21
End date: 2011-04-03
Betamethasone
Dosage: po
Administration route: Oral
Indication: Brain Neoplasm
Start date: 2011-02-15
End date: 2011-03-03
Other drugs received by patient: Trimethoprim; Cotrim; Famotidine
Possible Betamethasone side effects in male
Reported by a physician from Japan on 2012-03-30
Patient: male
Reactions: Bronchopulmonary Aspergillosis, Atrial Flutter, Gamma-Glutamyltransferase Increased, Insomnia, Blood Lactate Dehydrogenase Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Pirfenidone
Administration route: Oral
Start date: 2009-06-24
End date: 2009-07-07
Pirfenidone
Administration route: Oral
Start date: 2009-07-08
End date: 2010-12-30
Cyclophosphamide
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2011-01-21
End date: 2011-01-21
Pirfenidone
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2009-06-10
End date: 2009-06-23
Sandimmune
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2010-12-31
End date: 2011-01-25
Cyclophosphamide
Start date: 2011-01-05
End date: 2011-01-05
Pirfenidone
Administration route: Oral
Start date: 2010-12-31
End date: 2011-01-24
Betamethasone
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2011-01-01
End date: 2011-01-25
Other drugs received by patient: Alendronate Sodium; Amlodipine; Methylprednisolone Sodium Succinate; Fentanyl; Neoral; Daiphen; Prednisolone; Brotizolam; Warfarin Sodium; Diprivan; Valsartan; Elaspol; Prednisolone; Neoral; Theolong; Omeprazole; Midazolam; Inovan; Norepinephrine Bitartrate
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2012-03-23
Patient: 74 year old female, weighing 59.1 kg (130.0 pounds)
Reactions: Anaemia, Cerebral Atrophy, Device Related Infection, Oropharyngeal Candidiasis, Hypophagia, Oliguria, Delayed Effects of Radiation, Hypoalbuminaemia, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Betamethasone
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-09
Betamethasone
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-08-08
End date: 2009-08-11
Betamethasone
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-10-24
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Cortril
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-22
Cortril
Dosage: po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-11-10
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-09-10
End date: 2009-09-25
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-08-25
End date: 2009-08-29
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-06-01
End date: 2009-07-12
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-11-09
End date: 2009-11-13
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-08-10
End date: 2009-08-14
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-09-14
End date: 2009-10-16
Temodal
Dosage: 75;150;200; mg/qd, po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-10-12
End date: 2009-10-16
Other drugs received by patient: Gabapentin; Zosyn; Juzen-Taiho-TO; Atarax; Isotonic Sodium Chloride Solution; Bactrim; Depakene; Primperan TAB; Gentamicin Sulfate; Hepaflush; Mobenzocin; Phenobarbital TAB; Piperacillin Sodium; Amlodipine; Ramelteon; Amoxicillin; Mystan; Diazepam; Cravit (Levofloxacin Hydrate); Tegretol; Proheparum; Predopa; Soldem 3A (Maintenance Mediium 3); Lansoprazole; Olmesartan Medoxomil; Ubretid; Lactec (Lactated Ringer's Solution); Lactulose; Aspara (L-Aspartate Potassium); Mucosil-10; Isotonic Sodium Chloride Solution; Ebrantil; Soldem (3A (Maintenance Medium 3); Sodium Chloride; Enteronon R (Antibiotics-Resistant Lactic Acid Bacteriae); Cefazolin Sodium; Decadron; Zolpidem; Vancomycin Hydrochloride; Water FOR Injections; Seloken L; Rinderon-VG; Aminoleban (Amino Acid Preparations FOR Hepatic Insufficiency 1); Solyugen G (Acetated Ringer's Solution with Glucose 1); Phenytoin Sodium CAP; Zonisamide; Stronger NEO-Minophagen C; Sefirom
Possible Betamethasone side effects in 68 year old male
Reported by a physician from Japan on 2012-03-20
Patient: 68 year old male, weighing 65.0 kg (143.0 pounds)
Reactions: Disseminated Intravascular Coagulation, Palmar-Plantar Erythrodysaesthesia Syndrome, Pyrexia, Interstitial Lung Disease, Diarrhoea, Crepitations, Anal Haemorrhage, Cough, Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Nexavar
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2010-07-05
End date: 2010-07-13
Nexavar
Dosage: 400 mg, qod
Administration route: Oral
Start date: 2010-07-26
End date: 2010-09-04
Nexavar
Administration route: Oral
Start date: 2010-07-20
Betamethasone
Dosage: daily dose .5 df
Administration route: Oral
Start date: 2010-08-02
End date: 2010-09-04
Other drugs received by patient: MS Contin; Aminovact; Lansoprazole; Magmitt; Rhythmy; Morphine; Urso 250; Voltaren
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2012-03-20
Patient: 74 year old female, weighing 44.5 kg (97.9 pounds)
Reactions: Diabetes Mellitus, Aspartate Aminotransferase Increased, Neoplasm Progression, Glucose Urine Present, Brain Neoplasm
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Temodal
Dosage: 100 mg;qd;indrp ; 10 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-05-25
End date: 2011-05-29
Temodal
Dosage: 100 mg;qd;indrp ; 10 mg;qd;indrp
Indication: Glioblastoma Multiforme
Start date: 2011-02-21
End date: 2011-04-03
Betamethasone
Dosage: po
Administration route: Oral
Indication: Brain Neoplasm
Start date: 2011-02-15
End date: 2011-03-03
Other drugs received by patient: Flomox (Cefcapene Pivoxil Hydrochloride Hydrate); Famotidine; Meiactms; Bfluid (Mixed Amino Acid / Carbohydrate / Electrolyte / Vitamin Combined DRU; Norvasc; Solacet F (Acetateed Ringer;s Solution); Ramelteon; Famotidine; Losartan Potassium and Hydrochlorothiazide; Glyceol (Concentrated Glyceirn, Fructose); Sulfamethoxazole and Trimethoprim; Sodium Chloride; Serotone
Possible Betamethasone side effects in 61 year old male
Reported by a physician from Japan on 2012-03-13
Patient: 61 year old male
Reactions: Bronchopulmonary Aspergillosis, Gamma-Glutamyltransferase Increased, Atrial Flutter, Insomnia, Blood Lactate Dehydrogenase Increased
Adverse event resulted in: death
Drug(s) suspected as cause:
Pirfenidone
Administration route: Oral
Start date: 2009-06-24
End date: 2009-07-07
Pirfenidone
Administration route: Oral
Start date: 2010-12-31
End date: 2011-01-24
Betamethasone
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2011-01-01
End date: 2011-01-25
Cyclophosphamide
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2011-01-21
End date: 2011-01-21
Cyclophosphamide
Start date: 2011-01-05
End date: 2011-01-05
Sandimmune
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2010-12-31
End date: 2011-01-25
Pirfenidone
Administration route: Oral
Indication: Idiopathic Pulmonary Fibrosis
Start date: 2009-06-10
End date: 2009-06-23
Pirfenidone
Administration route: Oral
Start date: 2009-07-08
End date: 2010-12-30
Other drugs received by patient: Neoral; Brotizolam; Midazolam; Prednisolone; Prednisolone; Amlodipine; Prednisolone; Diprivan; Neoral; Omeprazole; Omeprazole; Norepinephrine Bitartrate; Warfarin Sodium; Fentanyl; Theolong; Dopamine HCL; Daiphen; Alendronate Sodium; Valsartan; Methylprednisolone Sodium Succinate; Elaspol
Possible Betamethasone side effects in 61 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-01
Patient: 61 year old male
Reactions: Hepatitis B
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Betamethasone
Dosage: x3 days post operation
Indication: Glioblastoma
Temozolomide
Possible Betamethasone side effects in 74 year old female
Reported by a physician from Japan on 2011-11-25
Patient: 74 year old female, weighing 59.1 kg (130.0 pounds)
Reactions: Oropharyngeal Candidiasis, Anaemia, Oliguria, Hypoalbuminaemia, Cerebral Atrophy, Device Related Infection, Thrombocytopenia
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-11-09
End date: 2009-11-13
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-06-01
End date: 2009-07-12
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-09-14
End date: 2009-09-18
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-08-10
End date: 2009-08-14
Temodal
Dosage: 75 mg/m2:qd;po, 150 mg/m2;qd;po, 200 mg/m2;qd;po, 150 mg/m2;qd;po, 100 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2009-10-12
End date: 2009-10-16
Cortril
Dosage: po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-22
Cortril
Dosage: po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-11-10
Betamethasone
Dosage: po; po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-08-08
End date: 2009-08-11
Betamethasone
Dosage: po; po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-09-01
End date: 2009-09-09
Betamethasone
Dosage: po; po; po
Administration route: Oral
Indication: Cerebral Atrophy
Start date: 2009-10-14
End date: 2009-10-24
Betamethasone Sodium Phosphate
Dosage: iv; iv; iv
Indication: Cerebral Atrophy
Start date: 2009-08-25
End date: 2009-08-29
Betamethasone Sodium Phosphate
Dosage: iv; iv; iv
Indication: Cerebral Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Betamethasone Sodium Phosphate
Dosage: iv; iv; iv
Indication: Cerebral Atrophy
Start date: 2009-09-10
End date: 2009-09-25
Betamethasone Sodium Phosphate
Dosage: iv
Indication: Cerebral Atrophy
Start date: 2009-08-20
End date: 2009-08-31
Other drugs received by patient: Mobenzocin; Ebrantil; Amoxicillin; Diazepam; Phenytoin Sodium CAP; Stronger NEO-Minophagen C; Atarax; Piperacillin Sodium; Ramelteon; Mystan; Gentamicin Sulfate; Cravit (Levofloxacin Hydrate); Zonisamide; Tegretol; Enteron R (Antibiotics-Resistant Lactic Acid Bacteriae); Sefirom; Solyugen G (Acetated Ringer's Solution with Glucose 1); Water FOR Injections; Mucosil-10; Sefmazon; Soldem 3A (Maintenance Medium 3); Amlodin OD; Olmesartan Medoxomil; Decadron; Gabapentin; Hepaflush; Zosyn; Sodium Chloride; Phenobarbital TAB; Juzen-Taiho-TO; Predopa; Isotonic Sodium Chloride Solution; Isotonic Sodium Chloride Solution; Lansoprazole; Rinderon-VG; Zolpidem; Solden (3A Maintenance Medium 3); Lactulose; Aminoleban (Amino Acid Preparations FOR Hepatic Insufficiency 1); Phoheparum; Primperan TAB; Vancomycin Hychloride; Aspara (L-Aspartate Potassium); Bactrim; Seloken L; Depakene; Ubretid; Lactec (Lactated Ringer's Solution)
Possible Betamethasone side effects in 61 year old male
Reported by a physician from Japan on 2011-10-11
Patient: 61 year old male, weighing 55.6 kg (122.3 pounds)
Reactions: Cardio-Respiratory Arrest, Urinary Tract Infection, Pulmonary Embolism, Hemiplegia
Adverse event resulted in: death
Drug(s) suspected as cause:
Betamethasone
Dosage: 2 mg;qd;po
Administration route: Oral
Start date: 2008-08-19
End date: 2008-11-17
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-04-29
End date: 2008-05-03
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-07-23
End date: 2008-07-27
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-09-17
End date: 2008-09-21
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-03-04
End date: 2008-03-08
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-11-05
End date: 2008-11-09
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2007-11-21
End date: 2008-01-08
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-08-20
End date: 2008-08-24
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-02-05
End date: 2008-02-09
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-04-01
End date: 2008-04-05
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-05-27
End date: 2008-05-31
Temodal
Dosage: 75 mg/m2;qd;po 150 mg/m2;qd;po 200 mg/m2;qd;po
Administration route: Oral
Indication: Anaplastic Astrocytoma
Start date: 2008-06-24
End date: 2008-06-28
Other drugs received by patient: Amlodin OD; Rabeprazole Sodium; Sulfamethoxazole; Feron; Cravit (Levofloxacin Hydrate)
Possible Betamethasone side effects in female
Reported by a physician from Japan on 2011-10-07
Patient: female
Reactions: Dermatitis Allergic, Sepsis, Toxic Epidermal Necrolysis, Liver Disorder
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Voltaren
Indication: Pyrexia
Start date: 2009-04-29
End date: 2009-04-29
Voltaren
Start date: 2009-05-10
End date: 2009-05-10
Acetaminophen
Administration route: Oral
Indication: Pyrexia
Start date: 2009-05-02
End date: 2009-05-06
Carnaculin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-04-01
End date: 2009-05-09
Betamethasone
Indication: Product Used FOR Unknown Indication
Start date: 2009-04-01
End date: 2009-05-09
Rocephin
Indication: Product Used FOR Unknown Indication
Start date: 2009-04-29
End date: 2009-05-10
Voltaren
Start date: 2009-05-01
End date: 2009-05-01
Voltaren
Start date: 2009-05-06
End date: 2009-05-06
Metilon
Indication: Pyrexia
Start date: 2009-05-01
End date: 2009-05-01
Voltaren
Start date: 2009-05-03
End date: 2009-05-03
Other drugs received by patient: Aspirin; Micardis
|
